Cargando…
IMT-05 PHASE III RANDOMIZED CLINICAL TRIAL OF AFTV FOR NEWLY DIAGNOSED GLIOBLASTOMA
BACKGROUND: The highly fatal glioblastoma has an extremely poor prognosis and development of a new treatment is desired. Local treatment is limited due to its high invasiveness, and immunotherapy utilizing self-immune mechanism is theoretically expected. An autologous formalin-fixed tumor vaccine (A...
Autores principales: | Nitta, Masayuki, Muragaki, Yoshihiro, Ishikawa, Eiichi, Maruyama, Takashi, Ikuta, Soko, Saito, Taiichi, Tsuzuki, Shunsuke, Fukui, Atsushi, Mastumura, Akira, Kawamata, Takakazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213209/ http://dx.doi.org/10.1093/noajnl/vdz039.079 |
Ejemplares similares
-
ACT-05 PREDICTIVE FACTORS RELATING TO OUTCOME AFTER RESECTION OF LOW-GRADE GLIOMAS WITHOUT CHEMOTHERAPY OR RADIOTHERAPY
por: Ikuta, Soko, et al.
Publicado: (2019) -
ACT-17 Protocol design of a matrix-type of novel clinical trial for lower-grade gliomas
por: Muragaki, Yoshihiro, et al.
Publicado: (2020) -
STMO-08 INFLUENCE OF WIDE OPENING OF THE LATERAL VENTRICLE ON SURVIVAL FOR SUPRATENTORIAL GLIOBLASTOMA PATIENTS WITH RADIOTHERAPY AND CONCOMITANT TEMOZOLOMIDE-BASED CHEMOTHERAPY
por: Saito, Taiichi, et al.
Publicado: (2019) -
ACT-22 CLINICAL RESULT AND CONSIDERATION OF 70 CASES OF INSULAR GLIOMA
por: Maruyama, Takashi, et al.
Publicado: (2019) -
STMO-11 CLINICAL EFFICACY OF AWAKE SURGERY: ANALYSIS OF 335 CASE ON EXTENT OF RESECTION AND SURVIVAL TIME
por: Fukui, Atsushi, et al.
Publicado: (2019)